Return to Listing

1 result(s) for

PI Name Protocol # Title
Ronan Swords STUDY00018684 Phase I Study to Evaluate the Safety and Tolerability of Gemtuzumab Ozogamicin (Mylotarg) in Combination with Cytarabine, Anthracycline and Midostaurin Induction for Patients with Newly Diagnosed FLT3 Positive Acute Myeloid Leukemia (AML)

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080